About Us
reasons why you should give us a trial.
When it comes to finding the right DCT partner, we know you’ve got options and that you always do your research. That’s why we invite you to get to know more about the “Delve Difference.”
FROM MINNESOTA TO THE WORLD
Based in Minneapolis, we have spent over 20 years helping clients improve clinical research outcomes through studies in North America, Europe, Asia and the Middle East/North Africa.
NOT OUR FIRST RODEO
We have supported over 100 studies and 26 registries in therapeutic areas including, but not limited to oncology, cardiovascular, endocrinology, dermatology and pediatric disorders.
WIDE INDUSTRY KNOWLEDGE
A FLEXIBLE FIT
We would never try to squeeze your trial into a pre-boxed solution. Our agile team of analysts, programmers and clinical operators work closely with you to address all of your studies’ needs.
LIVING ON THE CUTTING EDGE
In addition to our proprietary platform, our founding team has designed numerous applications on the strength of their technological know-how and deep understanding of life sciences.
ALWAYS COMPLIANT
We work closely with clients and take all the necessary steps to ensure data safety and security. We also meet regulatory requirements across all project phases, as we are 21CFRpart11, GDPR and HIPAA compliant.
The people at the center of our
patient—centric approach
Our global team of experts is committed to improving virtual, hybrid and
decentralized clinical studies with technology solutions that patients
want to use and researchers trust to deliver high-quality results. And it all starts with
our passionate experienced leadership group.
WESSAM SONBOL
FOUNDER & CEO
A proven biopharmaceuticals and healthcare solutions strategist focusing on life science process improvement, Wessam has nearly 20 years of experience in Phase I-IV, IDE and 510(K) clinical research and healthcare business operations. He’s successfully managed a data management organization and worked with Fortune 500 companies such as Medtronic, Abbott Vascular and Johnson & Johnson. Through breakthrough strategies, Wessam helps achieve notable results in improving clinical trial outcomes.
DAVE ALDERSON
VP OF BUSINESS DEVELOPMENT
Of his 30 years of experience, of which 10 were spent leading product development for MRI, PET and other diagnostic and treatment devices. Since then, he’s assembled and managed sales teams for custom and commercial software systems and related services to support and enhance clinical development. A frequent speaker and author on various clinical topics, Dave specializes in bringing the power of clinical systems to early- and late-stage development.
THERESA DAHL
DIRECTOR OF CUSTOMER SUCCESS
She has extensive experience in leading with strategic company initiatives in mind. Her expertise pushes our teams forward in program and account management—never losing focus to ensure we provide our clients the tools to deliver patient-centric healthcare and a cutting-edge platform to support medical device development. Theresa is dedicated to creating and maintaining long-term partnerships and essential relationships with key stakeholders, senior executives and team members to advance clinical outcomes and achieve customer success.
SAM BACARELLA
DIRECTOR OF BUSINESS DEVELOPMENT, US
With over 25 years of experience in Pharmaceutical Development, the last 15 of which are specifically in clinical research development, he’s assembled and managed sales teams for custom and commercial bio-analysis; specialized clinical trial logistics; and nurse provision for DCT, healthcare, and related services; all to support innovation in clinical development. Based in the USA, Sam specializes in real-world evidence (RWE), ePRO and registries studies.
